StoneX is showing high stability during turbulent times Strong earnings, low valuation, growing customer base – the financial services provider impresses with substance rather than speculation. In times of geopolitical tensions, the markets react nervously. While many investors are now betting on the usual suspects, one name consistently...
The Best Growth Stocks by Revenue Growth
Stocks with high revenue growth on a TTM basis, sorted by distance to the 52-week high.
| Rank | Stock | Price | Rev. Gr. | Dist. 52WH | Perf. 20D |
|---|---|---|---|---|---|
| WKN | Symbol | EPS Growth | Rel. Strength | |||
| 1 | Palomar Holdings | 130.13 $ | 40.22 % | 9.49 % | -0.24 % |
| A2PHB6 | PLMR | 49.48 % | 96 | |||
| 2 | HCI Group | 137.20 $ | 49.16 % | 9.67 % | -1.52 % |
| A1W02H | HCI | 199.39 % | 85 | |||
| 3 | Alignment Healthcare | 18.84 $ | 48.25 % | 10.54 % | 19.92 % |
| A2QSBM | ALHC | - % | 99 | |||
| 4 | HEICO | 187.93 $ | 43.13 % | 14.27 % | -5.63 % |
| 914043 | HEI/A | 19.31 % | 87 | |||
| 5 | Heico | 238.62 $ | 43.13 % | 15.86 % | -5.58 % |
| 889997 | HEI | 19.31 % | 88 | |||
| 6 | StoneX Group | 70.30 $ | 64.14 % | 17.76 % | -3.65 % |
| A2P8CE | SNEX | 7.01 % | 95 | |||
| 7 | Catalyst Pharmaceuticals | 20.86 $ | 32.17 % | 20.27 % | -1.62 % |
| A0LCUL | CPRX | 111.86 % | 90 | |||
| 8 | Newmont | 46.64 $ | 53.66 % | 20.57 % | 6.90 % |
| 853823 | NEM | - % | 83 | |||
| 9 | Rhythm Pharmaceuticals | 53.57 $ | 81.55 % | 21.89 % | 4.38 % |
| A2H5A0 | RYTM | - % | 87 | |||
| 10 | Mercadolibre | 1,842.40 $ | 43.63 % | 22.44 % | -8.13 % |
| A0MYNP | MELI | 43.98 % | 86 | |||
Subscribe now to see the full ranking
Already a subscriber? Login
Sample Issue
$
0
one issue
Bestseller
Trial Subscription
$
33
1 month